TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $878,000 | +126.3% | 75,000 | 0.0% | 0.04% | +50.0% |
Q3 2020 | $388,000 | +163.9% | 75,000 | 0.0% | 0.03% | +133.3% |
Q2 2020 | $147,000 | -42.6% | 75,000 | -50.0% | 0.01% | -20.0% |
Q1 2020 | $256,000 | -19.0% | 150,000 | +11.1% | 0.02% | -58.3% |
Q4 2019 | $316,000 | – | 135,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |